Pridgen William 13D and 13G filings for Virios Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 4:13 pm Purchase |
2023-02-13 | 13G | Virios Therapeutics, Inc. VIRI |
Pridgen William | 753,819 4.100% |
25,508 (+3.50%) |
Filing |
| 2022-02-14 09:46 am Purchase |
2021-12-31 | 13G | Virios Therapeutics, Inc. VIRI |
Pridgen William | 728,311 8.700% |
18,519 (+2.61%) |
Filing |
| 2021-02-16 4:44 pm Purchase |
2020-12-31 | 13G | Virios Therapeutics, Inc. VIRI |
Pridgen William | 709,792 8.500% |
709,792 (New Position) |
Filing |